The tally, one vote per house
10 of 12 research houses flag it as a material risk, +1 house in 30 days. See which houses, free →
The theme holds that a large wave of mega-IPOs and lockup expiries over the next 12-18 months could end net equity buybacks and add share supply that weighs on US stock prices. Ten houses argue for this view, with one against and one mixed, and researchers point to the planned Anthropic listing and the SpaceX float as examples of the supply risk. A minority counter-argument is that the Anthropic IPO may be priced conservatively and well received, so the supply pressure could prove less severe than feared.
Each house counts once: its newest view on the theme in the last 60 days. The counts are computed, not written by AI; the summary is AI-written from the houses’ views, without names.
Who the houses are
- Independent research firms5
- Podcasts4
- Banks2
- Asset manager1
Types only: names are shown to members. See who said what, free →
Houses discussing it, 12 weeks
Houses with a view in the 60 days to each week’s end. Latest: 12 houses on 3 Nov.
What houses expect if it happens
- US Equities lower
- ▼ Equities 3
Positioning
Source: CFTC Commitments of Traders; FinChiefs calculations. Report of 27 Oct 2026. Positioning data →
Named in research
No fund, ETF or index has been named by at least 2 research houses for this theme yet.
Questions
What is the “IPO equity supply” theme?
A large wave of mega-IPOs and lockup expiries over the next 12-18 months ends net equity buybacks and adds share supply that could weigh on US stock prices. It is one of 70 themes FinChiefs counts across published research from banks, asset managers, independent research firms and podcasts.
How many research houses flag this risk?
10 of 12 research houses flag it as a material risk (83%), counting each house's newest view in the last 60 days: 10 flag it as material, 1 is mixed and 1 call it overdone. That is +1 house in 30 days. Members see each house by name.
Which instruments do research houses name for this theme?
No fund, ETF or index has been named by at least 2 research houses for this theme yet.
Is this investment advice?
No. Themes summarise what research houses argue. FinChiefs takes no view of its own. Instruments shown are the ones research houses name, not selected or endorsed by FinChiefs. Not investment advice. No prices are shown and no instrument pays to appear.
The Daily Digest in your inbox
Every morning, what published research argued the day before: the cross-asset and macro read in full, then every market in a line.